FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Par Formulations Private Phenoxybenzamine Hydrochloride Capsules Recall

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist

Par Formulations Private Limited · Chennai, N/A

Risk level
Class II
Reported by FDA
Nov 23, 2022
Recall ID
D-0061-2023
Check your lot numberHow we source this data

Summary

Par Formulations Private recalled Phenoxybenzamine Hydrochloride Capsules starting Nov 10, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0061-2023 on Nov 23, 2022. Reason: Failed Impurities/Degradation Specifications. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications

Product description

Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01

Lot numbers, UPCs & expiration codes

Lot #: 15429401, Exp. Date 08/2023

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0061-2023
Classification
Class II
Status
Terminated
Recall initiated
Nov 10, 2022
FDA report date
Nov 23, 2022
Quantity
218 bottles/100 capsules per bottle
Recall type
Voluntary: Firm initiated
Recalling firm
Par Formulations Private Limited

Original FDA data

Every field from FDA enforcement report D-0061-2023, exactly as published.

Show all FDA fields
City
Chennai
Status
Terminated
Country
India
Event ID
91110
Address
9/215 Pudupakkam-Vandalur Main Road
Address (line 2)
Pudupakkam, Kelambakkam
Code information
Lot #: 15429401, Exp. Date 08/2023
Report date
Nov 23, 2022
Product type
Drugs
Recall number
D-0061-2023
Classification
Class II
Recalling firm
Par Formulations Private Limited
Product quantity
218 bottles/100 capsules per bottle
Termination date
Aug 18, 2023
Reason for recall
Failed Impurities/Degradation Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Phenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottles, RX only Dist. by: Par Pharmaceutical Chestnut Ridge, NY 10977 U.S.A. Mfg. by: Par Forumulations Private Limited,9/215, Pudupakkam, Kelambakkam - 603 103. NDC 49884-038-01
Distribution pattern
Nationwide within the United States
Recall initiation date
Nov 10, 2022
Initial firm notification
Letter
Center classification date
Nov 15, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0061-2023, published Nov 23, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls